Reversing the tumor growth dynamics in Havcr2fl/fl mice via anti-IL4 treatment has proven that TIM3 ablation enables an antigen-specific anti-tumor immunity (Fig. 1). This evidence concerns the gene HAVCR2 and neoplasm.